| Identification | Back Directory | [Name]
(1R,1'S,3'R/1R,1'R,3'S)-L-054,264 | [CAS]
208706-12-1 | [Synonyms]
264
3'R/1R
R,3'
S,3'
R,3'
(1R,1'
R,2S,2'
R/1R,1'
3'S)-L-054
S)-DuanPhos
-iodo-1'
(1R,1&rsquo
S)-L-054,264
-iodo-1&rsquo
-N-Cbz-amino-2'
(1R,1S,3R/1R,1R,3'S)
S)-Octahydro-1-(2'
[3S-(3S,4aS,8aS,2'
S)-Octahydro-1-(2&rsquo
-Hydroxy pravastatin sodium salt
(1R,1'S,3'R/1R,1'R,3'S)-L-054,264
-methylethyl)-7a-methyl-inden-4-ol
-methylethyl)-7a-methyl-inden-4-one
-(((2-Aminopropane-1,3-diyl)bis(oxy))bis(methylene))bis(phenylcyclopropanecarboxamide)
Spiro[1H-indene-1,4'-piperidine]-1'-carboxamide, N-[(1R)-2-[[[3-(aminomethyl)cyclohexyl]methyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxoethyl]-
N-[(1R)-2-[[[(1S*,3R*)-3-(AMINOMETHYL)CYCLOHEXYL]METHYL]AMINO]-1-(1H-INDOL-3-YLMETHYL)-2-OXOETHYL]SPIRO[1H-INDENE-1,4'-PIPERIDINE]-1'-CARBOXAMIDE
N-?[(1R)?-?2-?[[[3-?(Aminomethyl)?cyclohexyl]?methyl]?amino]?-?1-?(1H-?indol-?3-?ylmethyl)?-?2-?oxoethyl]?-spiro[1H-?indene-?1,?4'-?piperidine]?-?1'-?carboxamide | [Molecular Formula]
C33H41N5O2 | [MDL Number]
MFCD09971077 | [MOL File]
208706-12-1.mol | [Molecular Weight]
539.71 |
| Hazard Information | Back Directory | [Uses]
Somatostatin receptors are often overexpressed in tumours and are potential therapeutic targets. Somatostatin receptor agonists can be used to study signaling pathways related somatostatin receptor.N-?[(1R)?-?2-?[[[3-?(Aminomethyl)?cyclohexyl]?methyl]?amino]?-?1-?(1H-?indol-?3-?ylmethyl)?-?2-?oxoethyl]?-spiro[1H-?indene-?1,?4''-?piperidine]?-?1''-?carboxamide is a selective somatostatin sst2 receptor agonist. | [Biological Activity]
Potent and selective somatostatin sst 2 receptor agonist (K i values are 4, 537, 2480, 3614 and 5017 nM for cloned human sst 2 , sst 1 , sst 4 , sst 3 and sst 5 receptors respectively). | [storage]
Store at +4°C |
|
| Company Name: |
|
| Tel: |
821-50328103-801 18930552037 |
| Website: |
http://www.approvedhomemanagement.com/ShowSupplierProductsList13285/0.htm |
| Company Name: |
BOC Sciences
|
| Tel: |
|
| Website: |
https://www.bocsci.com |
|